Baker et al. have found out that the chemotherapeutic drugs daunorubicin and etoposide could upregulate ABCB1 expression only in CRC cells in which the ABCB1 promoter was almost unmethylated [127]. This evidence concerns the gene ABCB1 and colorectal carcinoma.